360 related articles for article (PubMed ID: 25797165)
1. Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents.
Meyers MJ; Anderson EJ; McNitt SA; Krenning TM; Singh M; Xu J; Zeng W; Qin L; Xu W; Zhao S; Qin L; Eickhoff CS; Oliva J; Campbell MA; Arnett SD; Prinsen MJ; Griggs DW; Ruminski PG; Goldberg DE; Ding K; Liu X; Tu Z; Tortorella MD; Sverdrup FM; Chen X
Bioorg Med Chem; 2015 Aug; 23(16):5144-50. PubMed ID: 25797165
[TBL] [Abstract][Full Text] [Related]
2. Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.
Gambini L; Rizzi L; Pedretti A; Taglialatela-Scafati O; Carucci M; Pancotti A; Galli C; Read M; Giurisato E; Romeo S; Russo I
PLoS One; 2015; 10(11):e0142509. PubMed ID: 26566224
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.
Gardiner DL; Skinner-Adams TS; Brown CL; Andrews KT; Stack CM; McCarthy JS; Dalton JP; Trenholme KR
Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1087-98. PubMed ID: 19883329
[TBL] [Abstract][Full Text] [Related]
4. Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum.
Miura T; Hidaka K; Azai Y; Kashimoto K; Kawasaki Y; Chen SE; de Freitas RF; Freire E; Kiso Y
Bioorg Med Chem Lett; 2014 Apr; 24(7):1698-701. PubMed ID: 24631188
[TBL] [Abstract][Full Text] [Related]
5. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.
Moura PA; Dame JB; Fidock DA
Antimicrob Agents Chemother; 2009 Dec; 53(12):4968-78. PubMed ID: 19752273
[TBL] [Abstract][Full Text] [Related]
6. Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets.
Qidwai T
Curr Drug Targets; 2015; 16(10):1133-41. PubMed ID: 25738296
[TBL] [Abstract][Full Text] [Related]
7. Antimalarial activity of HIV-1 protease inhibitor in chromone series.
Lerdsirisuk P; Maicheen C; Ungwitayatorn J
Bioorg Chem; 2014 Dec; 57():142-147. PubMed ID: 25462990
[TBL] [Abstract][Full Text] [Related]
8. Antimalarial evaluation of copper(II) nanohybrid solids: inhibition of plasmepsin II, a hemoglobin-degrading malarial aspartic protease from Plasmodium falciparum.
Mohapatra SC; Tiwari HK; Singla M; Rathi B; Sharma A; Mahiya K; Kumar M; Sinha S; Chauhan SS
J Biol Inorg Chem; 2010 Mar; 15(3):373-85. PubMed ID: 19946719
[TBL] [Abstract][Full Text] [Related]
9. Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion.
Nasamu AS; Glushakova S; Russo I; Vaupel B; Oksman A; Kim AS; Fremont DH; Tolia N; Beck JR; Meyers MJ; Niles JC; Zimmerberg J; Goldberg DE
Science; 2017 Oct; 358(6362):518-522. PubMed ID: 29074774
[TBL] [Abstract][Full Text] [Related]
10. Azole-based non-peptidomimetic plasmepsin inhibitors.
Kinena L; Leitis G; Kanepe-Lapsa I; Bobrovs R; Jaudzems K; Ozola V; Suna E; Jirgensons A
Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800151. PubMed ID: 30063266
[TBL] [Abstract][Full Text] [Related]
11. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
[TBL] [Abstract][Full Text] [Related]
12. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
Kumari M; Chandra S; Tiwari N; Subbarao N
BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
[TBL] [Abstract][Full Text] [Related]
13. Discovery and development of 2-aminobenzimidazoles as potent antimalarials.
Devine SM; Challis MP; Kigotho JK; Siddiqui G; De Paoli A; MacRaild CA; Avery VM; Creek DJ; Norton RS; Scammells PJ
Eur J Med Chem; 2021 Oct; 221():113518. PubMed ID: 34058708
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibitors of malarial aspartic proteases, the plasmepsins, by hydroformylation of substituted 7-azanorbornenes.
Aureggi V; Ehmke V; Wieland J; Schweizer WB; Bernet B; Bur D; Meyer S; Rottmann M; Freymond C; Brun R; Breit B; Diederich F
Chemistry; 2013 Jan; 19(1):155-64. PubMed ID: 23161835
[TBL] [Abstract][Full Text] [Related]
15. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
[TBL] [Abstract][Full Text] [Related]
16. Methyl-substitution of an iminohydantoin spiropiperidine β-secretase (BACE-1) inhibitor has a profound effect on its potency.
Egbertson M; McGaughey GB; Pitzenberger SM; Stauffer SR; Coburn CA; Stachel SJ; Yang W; Barrow JC; Neilson LA; McWherter M; Perlow D; Fahr B; Munshi S; Allison TJ; Holloway K; Selnick HG; Yang Z; Swestock J; Simon AJ; Sankaranarayanan S; Colussi D; Tugusheva K; Lai MT; Pietrak B; Haugabook S; Jin L; Chen IW; Holahan M; Stranieri-Michener M; Cook JJ; Vacca J; Graham SL
Bioorg Med Chem Lett; 2015 Nov; 25(21):4812-4819. PubMed ID: 26195137
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of gallinamide A analogues as potent falcipain inhibitors and antimalarials.
Conroy T; Guo JT; Elias N; Cergol KM; Gut J; Legac J; Khatoon L; Liu Y; McGowan S; Rosenthal PJ; Hunt NH; Payne RJ
J Med Chem; 2014 Dec; 57(24):10557-63. PubMed ID: 25412465
[TBL] [Abstract][Full Text] [Related]
18. Exploiting Structural Dynamics To Design Open-Flap Inhibitors of Malarial Aspartic Proteases.
Bobrovs R; Jaudzems K; Jirgensons A
J Med Chem; 2019 Oct; 62(20):8931-8950. PubMed ID: 31062983
[TBL] [Abstract][Full Text] [Related]
19. A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress.
Pino P; Caldelari R; Mukherjee B; Vahokoski J; Klages N; Maco B; Collins CR; Blackman MJ; Kursula I; Heussler V; Brochet M; Soldati-Favre D
Science; 2017 Oct; 358(6362):522-528. PubMed ID: 29074775
[TBL] [Abstract][Full Text] [Related]
20. Fast-Acting Small Molecules Targeting Malarial Aspartyl Proteases, Plasmepsins, Inhibit Malaria Infection at Multiple Life Stages.
Singh S; Rajendran V; He J; Singh AK; Achieng AO; Vandana ; Pant A; Nasamu AS; Pandit M; Singh J; Quadiri A; Gupta N; Poonam ; Ghosh PC; Singh BK; Narayanan L; Kempaiah P; Chandra R; Dunn BM; Pandey KC; Goldberg DE; Singh AP; Rathi B
ACS Infect Dis; 2019 Feb; 5(2):184-198. PubMed ID: 30554511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]